Phase I/II Study of Split-dose TPF-Induction Chemotherapy Before Surgery of Oropharyngeal and Cavity of the Mouth Cancer.

Trial Profile

Phase I/II Study of Split-dose TPF-Induction Chemotherapy Before Surgery of Oropharyngeal and Cavity of the Mouth Cancer.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 09 Sep 2016

At a glance

  • Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Fluorouracil (Primary)
  • Indications Oropharyngeal cancer
  • Focus Therapeutic Use
  • Acronyms TISOC-1
  • Most Recent Events

    • 02 Mar 2016 Status changed from active, no longer recruiting to completed, as reported by European Clinical Trials Database record.
    • 05 Oct 2013 Status changed from recruiting to suspended as reported by European Clinical Trials Database.
    • 02 Jun 2012 Other source identified and integrated: european Clinical Trials Database record EudraCT2009-011902-41.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top